Bob White

Operating Partner
Bachelor of Science Aerospace Engineering, University of Missouri-Rolla
Master of Business Administration, Cornell University

Bob White joined EW Healthcare in May 2019 as an Operating Partner.  Bob has nearly 30 years of experience leading early stage companies and Fortune 500 business units within the medical technology sector.  Bob most recently served as President and Chief Executive Officer of Entellus Medical, Inc. which was acquired by Stryker in February 2018.  Bob made a measurable impact at Entellus as a strong and passionate leader within the ear nose & throat surgery space, driving his business to successfully treat over 250,000 patients suffering from chronic sinusitis, Eustachian tube dysfunction and airway obstruction.  In 2018 Bob was recognized as a finalist in the Ernst & Young Entrepreneur of the Year and the YPO Global Innovation Award.  Bob currently serves as a Director on the Board of portfolio companies Cardiva Medical (acquired by Haemonetics) and TissueTech.

Previously, Bob was the President and Chief Executive Officer of TYRX, Inc. which specialized in commercializing innovative, implantable combination drug and device products focused on infection control until TYRX was sold to Medtronic in 2014.  Along the way TYRX was named to the Fierce Medical Devices “Fierce 15”, designating it as one of the leading medical device and diagnostic companies.

Prior to joining TYRX, Bob held several executive positions with Medtronic including serving as President of Physio Control, Vice President of Commercial Operations of the Cardiac Rhythm Disease Management business, and President of Kyphon following its $3.9 billion acquisition of the spinal treatment business. Earlier in his career, Bob held leadership positions in business development, international sales and marketing, operations, and general management with Instromedix/Life Watch, Eli Lilly, IVAC/Alaris Medical, and General Electric.

Bob currently also serves as a Director on the Board of Atricure Inc. (NASDAQ: ATRC).  During the past year two other companies which Bob actively served as a Director were acquired for significant premiums including Novadaq Technologies and privately held Hyperbranch Medical Technology.

Bob holds a B.S. in Aerospace Engineering from the University of Missouri-Rolla and an M.B.A. from Cornell University.